Unicycive Therapeutics, Inc.
UNCY
Revenue
675.00k
▼-276.00k▼-29.02%
6 Months ChangeAssets
50.61M
▲20.62M▲68.73%
3 Months ChangeLiabilities
13.13M
▼-435.00k▼-3.21%
3 Months ChangeFree Cash Flow
-8.92M
▼-2.46M▼-38.02%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2025-11-14
Form 8-K
ID: 0001213900-25-111045
2025-11-12
Form 8-K
ID: 0001213900-25-108847
2025-11-12
Form 10-Q
ID: 0001213900-25-108600
2025-10-28
Form 8-K
ID: 0001213900-25-102790
2025-08-18
Form 8-K
ID: 0001213900-25-077937
2025-08-15
Form 8-K
ID: 0001213900-25-077497
2025-08-14
Form 8-K
ID: 0001213900-25-076066
2025-08-14
Form 10-Q
ID: 0001213900-25-076007
2025-07-08
Form 8-K
ID: 0001213900-25-061936
2025-06-30
Form 8-K
ID: 0001213900-25-059303